% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{LeCornet:153788,
author = {C. Le Cornet$^*$ and B. Walter and D. Sookthai$^*$ and T.
S. Johnson$^*$ and T. Kühn$^*$ and E. Herpel and R.
Kaaks$^*$ and R. Turzanski-Fortner$^*$},
title = {{C}irculating 27-hydroxycholesterol and breast cancer
tissue expression of {CYP}27{A}1, {CYP}7{B}1, {LXR}-β, and
{ER}β: results from the {EPIC}-{H}eidelberg cohort.},
journal = {Breast cancer research},
volume = {22},
number = {1},
issn = {1465-542X},
address = {London},
publisher = {BioMed Central},
reportid = {DKFZ-2020-00454},
pages = {23},
year = {2020},
note = {#EA:C020#LA:C020#},
abstract = {Experimental and epidemiological studies demonstrate a role
for 27-hydroxycholesterol (27HC) in breast cancer
development, though results are conflicting. Cholesterol
27-hydroxylase (CYP27A1) and oxysterol 7-alpha-hydroxylase
(CYP7B1) regulate 27HC concentrations, while differential
expression of the liver X receptor (LXR) and estrogen
receptor beta (ERβ) may impact the association between 27HC
and breast cancer risk.We evaluated correlates of tumor
tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ and
the association between circulating prediagnostic 27HC
concentrations and breast cancer risk by marker expression
in a nested case-control study within the European
Prospective Investigation into Cancer and Nutrition
(EPIC)-Heidelberg cohort including 287 breast cancer cases
with tumor tissue available. Tumor protein expression was
evaluated using immunohistochemistry, and serum 27HC
concentrations quantified using liquid chromatography-mass
spectrometry. Conditional logistic regression models were
used to estimate odds ratios (ORs) and $95\%$ confidence
intervals (CIs).A higher proportion of CYP7B1-positive cases
were progesterone receptor (PR)-positive, relative to
CYP7B1-negative cases, whereas a higher proportion of
ERβ-positive cases were Bcl-2 low, relative to
ERβ-negative cases. No differences in tumor tissue marker
positivity were observed by reproductive and lifestyle
factors. We observed limited evidence of heterogeneity in
associations between circulating 27HC and breast cancer risk
by tumor tissue expression of CYP27A1, CYP7B1, LXR-β, and
ERβ, with the exception of statistically significant
heterogeneity by LXR-β status in the subgroup of women
perimenopausal at blood collection (p = 0.02).This
exploratory study suggests limited associations between
tumor marker status and epidemiologic or breast cancer
characteristics. Furthermore, the association between
circulating 27HC and breast cancer risk may not vary by
tumor expression of CYP27A1, CYP7B1, LXR-β, or ERβ.},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32075687},
doi = {10.1186/s13058-020-1253-6},
url = {https://inrepo02.dkfz.de/record/153788},
}